Factor H Antibody (Monoclonal - #2)
A murine monoclonal antibody to human Factor H
Product Specifications
Citations | 7 |
---|---|
Clonality |
Monoclonal |
Immunogen | Purified human protein. |
Applications | See citations and technical data sheet for application info. |
Concentration | 1.0-1.2 mg/mL |
Conjugate | Unconjugated |
Cross Reactivity |
Human, Baboon, Cynomolgus Monkey |
Ordering Information
Catalog Number | A254 |
---|---|
Catalog Number (CE) | N/A |
Size | 100 µl |
Price (USD) | $365.00 |
Price (EURO) | 330,00 € |
Contact us
US Phone | +1 (858) 552 1100 |
---|---|
EU Phone | +353 (91) 412 474 |
US Email | contact-us@quidelortho.com |
EU Email | contact-emea@quidelortho.com |
- Specifications
- Citations
- Certificate of Analysis
Specifications
Description |
A murine monoclonal antibody to human Factor H |
---|---|
Size | 100 µl |
Concentration |
1.0-1.2 mg/mL |
Applications | See citations and technical data sheet for application info. |
Form | Liquid. Borate Buffered Saline (pH 8.4 ± 0.2), with ≤ 0.1% Sodium Azide. |
Clonality | Monoclonal |
Immunogen | Purified human protein. |
Conjugate | Unconjugated |
Cross Reactivity | Human, Baboon, Cynomolgus Monkey |
Isotype | IgG1k |
Purity | > 95% by SDS PAGE |
Source |
Mouse |
Specificity | This monoclonal antibody was raised against purified human Factor H. |
Storage |
Short term (30 days) 4˚C. Long term at or below –20˚C. |
Background |
Factor H is a fluid phase complement regulatory protein consisting of a single peptide chain of 20 short consensus repeat segments or CCP’s with a molecular weight of approximately 155 KD. Factor H regulates the alternative pathway of the complement system by modifying activity of the “feedback loop.” It does this in three ways. First, it is a co-factor for the serine protease Factor I, which cleaves C3b to iC3b. iC3b has no hemolytic or amplification function, but may be bound by complement receptors. Second, Factor H prevents the formation of and accelerates the disassociation of the alternative pathway C3 convertase, C3bBb from cell surfaces. Finally, Factor H binds to polyanions on host cell surfaces and tissue matrices, such as basement membranes, blocking deposition of C3b. This later activity is leveraged by many pathogens as a mode of complement evasion. Recent studies have linked Factor H to hemolytic uremia syndrome (HUS), age-related macular degeneration (AMD), 4 and membrano-proliferative glomerulonephritis. Factor H may also be elevated in certain cancers, including bladder cancer, potentially as a protective measure used by tumor cells to evade complement attack. |
Citations
Title | Year | Applications | Sample Species | Sample | Sample Details |
---|---|---|---|---|---|
2020 | ELISA |
Cell Culture |
Jurkat Cells |
||
2021 | ELISA |
Human |
Eye Tissue |
Age-Related Macular Degeneration |
|
Clinicopathologic Implications of Complement Genetic Variants in Kidney Transplantation. |
2021 | ELISA |
Human |
Protein |
Factor H WT and Variants |
2016 | ELISA |
Human |
Purified Protein |
||
2016 | ELISA |
Human |
Serum |
||
2015 | FC |
Human |
Serum |
N. gonorrhoeae incubated |
|
Mechanisms by which Factor H protects Trypanosoma cruzi from the alternative pathway of complement |
2024 | FC |
Parasite |
Trypomastigotes, Epimastigotes |
Chagas disease |